NCT03145259View on ClinicalTrials.gov

Evaluation of Bioavailability of Diclofenac Dermal Products

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 19, 2017

Primary Completion Date

August 29, 2019

Study Completion Date

May 15, 2020

Conditions
Bioavailability
Interventions
DRUG

Diclofenac Epolamine Patch

patch

DRUG

diclofenac sodium solution

solution

Trial Locations (1)

21201

General Clinical Research Center (GCRC) at the University of Maryland Medical Center, Baltimore

All Listed Sponsors
collaborator

Food and Drug Administration (FDA)

FED

lead

University of Maryland, Baltimore

OTHER

NCT03145259 - Evaluation of Bioavailability of Diclofenac Dermal Products | Biotech Hunter | Biotech Hunter